Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer
Background. Difficulties in the prevention and treatment of endometrial pathology in hormone-positive breast cancer are associated with the lack of an unambiguous understanding of the mechanisms of the effect of tamoxifen on target tissues and the development of possible hyperestrogenism.Aim. To stu...
Saved in:
| Main Authors: | A. Yu. Goryainova, A. I. Stukan, A. I. Trofimenko, A. A. Meshcheryakov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-05-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/1051 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Features of ultrasound of endometrial pathological conditions in breast cancer patients receiving tamoxifen: a review of literature
by: M. A. Chekalova, et al.
Published: (2020-06-01) -
Rapamycin inhibits tamoxifen-induced endometrial proliferation in vitro as a pilot approach for endometrial protection in breast cancer
by: Akiko Nakamura, et al.
Published: (2025-01-01) -
Machine learning Nomogram for Predicting endometrial lesions after tamoxifen therapy in breast Cancer patients
by: Cao Shaoshan, et al.
Published: (2025-01-01) -
Ultrasonic, hysteroscopic and histological evaluation of the endometrium in women receiving tamoxifen for breast cancer
by: N. S. Melnikova, et al.
Published: (2014-07-01) -
Younger tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer and the risk could be reduced by sequenced aromatase inhibitor use: A population-based study in Taiwan
by: Sung-Chao Chu, et al.
Published: (2020-01-01)